Skip to content
Clinical Trial Events
ISPOR Europe 2026

Panel

The Non-3G (GENEROUS, GLOBE, GUARD) Pricing Paradox: Navigating the "MFN Trap" Opportunities and Risk in Latin America, the Middle East, and Asia

Mon, Nov 9, 2026 · 12:15–1:15 PM CET Hall F2, Level 0, Austria Center Vienna

About this session

MFN is reshaping how companies prioritize launch markets, with 19 markets currently included across the GENEROUS, GLOBE, and GUARD programs. While these “non-3G” markets may represent opportunities for earlier launches following the US, their health systems continue to face significant budget constraints driven by macroeconomic pressures, including inflation, currency devaluation, and geopolitical instability.

Speakers